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Abstract
MicroRNAs are key regulators associated with numerous diseases. In HEK293 cells, miR-
153-3p and miR-205-5p down-regulate alpha-synuclein (SNCA) and Leucine-rich repeat
kinase 2 (LRRK2), two key proteins involved in Parkinson’s disease (PD). We have used
two-dimensional gel electrophoresis (2D-PAGE) coupled to mass spectrometry (MS) to
identify a spectrum of miR-153-3p and miR-205-5p targets in neuronal SH-SY5Y cells. We
overexpressed and inhibited both microRNAs in SH-SY5Y cells and through comparative
proteomics profiling we quantified ~240 protein spots from each analysis. Combined, thirty-
three protein spots were identified showing significant (p-value < 0.05) changes in abun-
dance. Modulation of miR-153-3p resulted in seven up-regulated proteins and eight down-
regulated proteins. miR-205 modulation resulted in twelve up-regulated proteins and six
down-regulated proteins. Several of the proteins are associated with neuronal processes,
including peroxiredoxin-2 and -4, cofilin-1, prefoldin 2, alpha-enolase, human nucleoside
diphosphate kinase B (Nm23) and 14-3-3 protein epsilon. Many of the differentially
expressed proteins are involved in diverse pathways including metabolism, neurotrophin
signaling, actin cytoskeletal regulation, HIF-1 signaling and the proteasome indicating that
miR-153-3p and miR-205-5p are involved in the regulation of a wide variety of biological
processes in neuroblastoma cells.
Introduction
Parkinson’s disease (PD) is the most common neurodegenerative movement disorder charac-
terized by degeneration of dopaminergic neurons in the substantia nigra pars compacta [1].
Most PD cases are sporadic but genetic lesions in alpha-synuclein (SNCA) [2], Parkin [3],
PINK1 [4], DJ-1 [5] and Leucine-rich repeat kinase 2 (LRRK2) [6] have been associated with
both early- and late-onset PD. Despite extensive studies the molecular pathways leading to the
onset and progression of PD are poorly understood.
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MicroRNAs have been used to decode different pathways associated with several diseases
[7]. However, microRNA studies within neurodegeneration are limited. In terms of PD, miR-
7/miR-153 and miR-205-5p have been shown to down-regulate SNCA and LRRK2, respec-
tively whilst DJ-1 and Parkin are regulated by miR-34b/c [8, 9, 10]. Indirect regulatory effects
on PD-associated proteins have also been reported for miR-133b, miR-433, miR-184 and let-7
[11, 12, 13]. Despite limited data on microRNA regulatory pathways associated with neurode-
generation [14], microRNAs are associated with neuronal stem cell differentiation and devel-
opment, synapse formation and synaptic plasticity [11, 15].
Individual microRNAs can regulate several mRNAs [16]. Therefore, comparative proteomics
profiling in cells with altered microRNA levels has the potential to reveal new microRNA target
proteins. The aim of this study was to combine microRNA and proteomics technologies to iden-
tify new miR-153-3p and miR-205-5p targets in neuronal SH-SY5Y cells. We selected 2D-PAGE
as opposed to LC-MS as although LC-MS analysis is more comprehensive 2D-PAGE offers the
possibility of identifying more subtle changes in protein abundance. Several of the protein targets
identified are associated with neuronal processes and key regulatory pathways, indicating that
miR-153-3p and miR-205-5p are involved in a wide variety of biological processes.
Materials and Methods
Cell culture and transient cell transfection
SH-SY5Y cells (CRL-2266; ATCC) were cultured in a base medium mixture (Full medium: 1:1
DMEM/Ham’s-F12) (Invitrogen) supplemented with 10% v/v fetal bovine serum (Atlanta bio-
logics) and 2 mMGlutaMAX (Invitrogen) in 5% CO2 atmosphere at 37°C. Transfections were
performed, in triplicate, with scrambled control mimic, miR-153-3p mimic, miR-205-5p
mimic, scrambled control hairpin inhibitor, miR-153-3p hairpin inhibitor and miR-205 hair-
pin inhibitor, all mirVanaTM (Life Technologies), at a final concentration of 20 nM. Cells were
seeded in 6-well plates at 5x105 cells/well. 2μl μRNA (20 μM), diluted with 100 μl of Opti-
MEM, and 7 μl Lipofectamine RNAiMax (Invitrogen) diluted with 100 μl of Opti-MEM was
incubated for 5 minutes (min) at room temperature (RT). The two solutions were mixed and
incubated for 15 min at RT. The transfection mix was diluted to 2 ml with Opti-MEM, added
to the wells and incubated at 37°C for 4–6 hours before replacing with full media. Cells were
harvested after 24 hours for quantitative PCR (qRT-PCR) analysis and after 48 hours for West-
ern blotting and 2D-PAGE analysis.
RNA isolation, RT-PCR and quantitative real-time PCR
RNA was isolated, in triplicate, 24 hours post-transfection using the miRCURY RNA isolation
kit (Exiqon) treated with 1 unit/μg of RNA of DNaseI (Thermo Scientific) for 30 minutes at
37°C followed by 10 min at 65°C with 50mM EDTA. cDNA was synthesized using the
qScriptTM microRNA cDNA Synthesis kit (Quanta Biosciences) and used for both semi-quan-
titative (25 cycles) and qRT-PCR. miR-153-3p forward primer (5’ GCCGGGCTTGCATAGT
CACAA 3’), miR-205-5p forward primer (5’ GTTTCCTTCAT TCCACCGG 3’), U6 forward
primer (5’ CGCTTCGGCAGCACATATAC 3’) and PerfeCTa1Universal PCR primer along
with PerfeCTa1 SYBR1 GREEN SuperMix for IQTM were used for qRT-PCR in triplicates for
each biological replicate.
Western blotting
Whole cell lysates were prepared using RIPA buffer (150mM NaCl, 1% w/v NP40, 50mM Tris
pH 8.0, 0.5% w/v Sodium deoxycholate, 0.1% w/v SDS) 48 hours post-transfection and used for
miR153-3p and miR205-5p Protein Targets in SH-SY5Y Cells
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western blot analysis following published protocol [17]. Primary antibodies used are shown in
S1 Table. The secondary antibodies used were goat anti-rabbit or a goat anti-mouse secondary
antibody (Jackson Immunoresearch). The reported western blot results are representative of
n = 3.
Two-dimensional gel electrophoresis
Sample preparation. Total protein lysates were prepared using Urea solublization buffer
(7M Urea, 2M Thiourea, 4% (w/v) CHAPS and 30mM Tris, 1X protease/phosphatase inhibitor
cocktail) and sonication. The supernatant of centrifuged lysates was concentrated using Ami-
con1 Ultra centrifugal filters (10,000 MWCO). Protein concentrations were determined using
the Bradford assay (Bio-Rad).
2D-PAGE. Protein lysates were diluted with rehydration buffer (7 M urea, 2M thiourea,
2% (w/v) CHAPS, 40 mM DTT, 0.5% IPG buffer, pH 3–10 NL, and 0.4% Bromophenol Blue)
and applied to ImmobilineTM DryStrip 7 cm, pH 3–10 NL (GE Healthcare) for overnight pas-
sive rehydration. Isoelectric focusing was conducted on a PROTEAN1 IEF Cell, according to
the manufacturer’s recommendation (Bio-Rad). Following rehydration, proteins were reduced
with DTT and subsequently alkylated with iodoacetamide in equilibration buffer (6M Urea,
2.5% SDS, 50mM Tris, pH 8.8, 20% glycerol). Electrophoresis in the second dimension was
performed on 12% SDS-PAGE at 100V. Gels were stained overnight with colloidal Coomassie
Blue G-250 [18].
Scanning and analysis of the images. Gels were scanned using EPSON scan perfection
V750 PRO software (Digital ICE technologies) at 600 dpi/16-bit grayscale. ImageMaster 2D
platinum 7 (GE Healthcare) was used for spot detection, background subtraction, matching,
and to identify statistically significant (ANOVA) differences between protein spots i.e. fold
change over control. The experiments were performed in triplicate.
In-gel digestion. The differentially expressed protein spots were excised, cut into small
pieces and placed in 0.6 ml Eppendorf tubes. The gel pieces were destained by incubating in
200 μl of 100 mM ammonium bicarbonate: acetonitrile (50:50 v/v) with shaking. When fully
destained, the gel fragments were dehydrated with two washes of 100 μl of 100% acetonitrile
(ACN) and were then dried in a vacuum centrifuge (Speed-Vac) for 5 min. The proteins were
then cleaved enzymatically into peptides. For this, trypsin solution (2 μl of 0.02 μg/μl) was
added to the wet the gel pieces and incubation was carried out for 4 hours at RT. Thirty μl of 50
mM ammonium bicarbonate was added to the gel pieces and left overnight at RT to allow for
diffusion of the peptides from the gel. The digested proteins were stored at -80°C until further
analysis.
Peptide mass fingerprinting. After digestion, POROS 20 R2 resin (Applied Biosystems)
was added to the digested gel samples with 5% formic acid and 0.2% trifluoroacetic acid for
extraction at 4°C for 4 hours on a shaker. Prior to MALDI-MS analysis, the peptide digests
were further desalted using ZipTip C18 (Millipore). The ZipTips were conditioned with 10 μl of
0.1% TFA twice, 70% ACN/0.1% TFA twice, and 10 μl of 0.1% TFA twice. Samples containing
the digest and bead mixture were transferred to the ZipTips and bound to the C18 resin. The
loaded tips were then washed with 10 μl of 0.1% TFA. The peptide digests were eluted by plac-
ing 2 μl of 10 mg/mL CHCAmatrix solution in 0.003% TFA, 13% ethanol, and 84% ACN onto
the top of the ZipTips and slowly dispensing onto the MALDI plate. Mass spectrometric analy-
sis was performed using a Thermo LTQ XL linear ion trap mass spectrometer (Thermo Scien-
tific) equipped with a vacuumMALDI source, after the solvent evaporated at RT and the
CHCA matrix was crystallized with peptides on the MALDI plate. A data-dependent acquisi-
tion was performed using Xcalibur software, in which the top 40 of the most abundant
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precursor ions from the survey scan (mass range 700–3500 Da) were chosen and MS/MS
acquisition was triggered to fragment them by CID (collision-induced dissociation). The nor-
malized collision energy was 50%, and the isolation width was 3 Da. The raw-files from the
LTQ mass spectrometer were analyzed by using Mascot Distiller 2.3.2 (Matrix Science, Boston,
MA) for protein identification. Peptide masses were matched against the taxonomyHomo sapi-
ens in the National Centre for Biotechnology Information non-redundant (NCBInr) database.
One missed trypsin cleavage per peptide was allowed and an initial mass tolerance of 0.3 Da
was used in all searches. Complete carboxyamidation of cysteine sulfhydryls and partial oxida-
tion of methionine were assumed [19].
Cell viability and reactive oxygen species measurements
Cell viability was measured using the neutral red uptake assay 48 hours post-transfection. Cells
were washed with PBS, 100μl of neutral red working solution (40μg/ml) added to each well and
plates were incubated for 2 hours. Cells were then washed with PBS, neutral red extracted
using 150μl of destain solution (50% ethanol, 1% glacial acetic acid, 49% deionized water) per
well and the plates were subjected to shaking for 10 min. Absorbance was measured at 540nm
using an Epoch microplate spectrophotometer (BioTeck).
Cellular reactive oxygen species (ROS) were measured using 2’, 7’- dichlorofluoresceine dia-
cetate (DCF-DA) (Sigma-Aldrich). Cells were plated on solid black opaque plates at 5x104 cells
per well and after 48 hours incubated with 100μl of DCF-DA (25μM) for 45 min. Fluorescence
was measured using a GLoMas1-Multi Detection System fluorescence plate reader (Promega)
at 485nm (excitation) and 528nm (emission). The assays were performed in triplicate.
Image analysis, statistical analysis and contextual analysis
Western blot images were analyzed using IQTL software (GE Healthcare). Microsoft excel
tools was used for two-tailed Student’s t-test. The standard error was used to display variation.
The targets of miR-153-3p and miR-205-5p were used as input queries for the Partek Geno-
mics Suite software, version 6.6 (Partek) to perform Gene ontology (GO) analysis and generate
interactive maps and pathways.
Results and Discussion
Overexpression and inhibition of miR-153-3p and miR-205-5p in
SH-SY5Y cells
miR-153 overexpression in HEK293 cells downregulate SNCA whilst miR-205 overexpression
in HEK293 cells has been shown to downregulate LRRK2 [8, 9]. In this study, we selected the
neuroblastoma cell line SH-SY5Y as its neuronal characteristics represents a better platform to
dissect microRNA-regulated pathways and mechanisms associated with PD. miR-153-3p was
successfully overexpressed using miR-153-3p mimic and inhibited using miR-153-3p antago-
mir in SH-SY5Y cells (Fig 1A and 1B). Similarly, miR-205-5p was successfully overexpressed
using miR-205-5p mimic and inhibited using miR-205-5p antagomir (Fig 1A and 1B). Further,
we used qPCR to verify the down regulation of both the microRNAs due to the antagomirs
(Fig 1C).
Altered levels of miR-153-3p and miR-205-5p results in protein changes
associated with a spectrum of biological processes
We next sought to identify additional targets of miR-153-3p and miR-205-5p in SH-SY5Y cells
using 2D-PAGE analysis. However, before performing 2D-PAGE analysis we showed that
miR153-3p and miR205-5p Protein Targets in SH-SY5Y Cells
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miR-153-3p and miR-205-5p transfections had no significant effect on SH-SY5Y cell viability
ensuring that any observed protein changes were due to changes in miR-153-3p and miR-205-
5p levels (Fig 1D).
We performed comparative 2D-PAGE analysis comparing control mimic and control
antagomir transfected cells with cells transfected with the miR-153-3p mimic and the miR-
153-3p antagomir, respectively (Fig 2). The same comparative analyses were performed for
SH-SY5Y cells transfected with the miR-205-5p mimic and the miR-205-5p antagomir (Fig 3).
We identified thirty-three protein spots that showed significant abundance changes (fold
change> 1.4, n = 3, p-value< 0.05) between control transfected and miR-153-3p/miR-205-5p-
transfected SH-SY5Y cells. In response to altered levels of miR-153-3p seven protein spots were
up-regulated whilst eight protein spots were down-regulated (Fig 2, Table 1). In response to miR-
205-5p perturbations twelve protein spots were up-regulated whilst six protein spots were down-
regulated (Fig 3, Table 1). The protein spots were subjected to MS and the fragment spectra were
searched against the NCBInr database (taxonomyHomo sapiens) using Mascot Distiller revealing
the identity of the differentially expressed proteins (S1 Fig; Table 1, S2 Table).
Regulation of key neuronal processes by miR-153-3p and miR-205-5p
Overexpression of miR-153-3p resulted in up-regulation of proteasome subunit alpha type-1
isoform 2 (PSMA1) (Table 1, spot 4; S2 Fig). miR-205-5p overexpression also increased the
abundance of proteasome subunit p42 (PSMC6) (Table 1, spot 24; S2 Fig) and proteasome sub-
unit alpha type-1 isoform 2 (PSMA1) (Table 1, spot 21). Efficient proteasome activity is vital in
neurons as inappropriate degradation of misfolded proteins, such as amyloids and SNCA,
results in aggregate formation, a hallmark of AD and PD [12, 20].
miR-153-3p overexpression also resulted in increase abundance of Prefolding subunit 2
(PFDN2) (Table 1, spot 7), which transfers misfolded proteins to chaperonin ensuring proper
folding [21]. This indicates that miR-153-3p may up-regulate PFDN2 in response to increased
levels of misfolded proteins as a neuroprotective mechanism.
We also found that cathepsin Z (CTSZ) (Table 1, spot 13) is down-regulated in response to
miR-153-3p inhibition. In aging mouse brains cathepsin is upregulated, impairing neuronal
Fig 1. Overexpression and inhibition of miR-153-3p andmiR-205-5p and their effect on cell viability in
SH-SY5Y cells. (A-B) Semi-quantitative RT-PCR analysis showing miR-153-3p expression levels in
response to mimic (A) and antagomir (B) transfections. miR-205-5p expression levels in response to mimic
(A) and antagomir (B) transfections. (C) qRT-PCR analysis confirming the antagomir mediated inhibition of
miR-153-3p (C) and miR-205-5p. (D) Cell viability assay. U6 was used as loading controls for qRT-PCR.
Error bars indicate SEM (n = 3); *, p < 0.05, ***; p < 0.001.
doi:10.1371/journal.pone.0143969.g001
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survival and neuritogenesis, indicating that miR-153-3p may regulate cathepsin levels to main-
tain a healthy neuronal population [22].
Inhibition of miR-153-3p also results in the up-regulation of the calcium activated chloride
channel family member 4 (CLCA4) (Table 1, spot 9). Calcium activated chloride channels are
highly expressed in microglia and activated microglia and a reduction in toxicity is seen in
response to CLCA inhibitors [23]. CLCA4 inhibition by miR-153-3p may contribute to
neuroprotection.
The stress-induced phosphoprotein 1 (STIP1) (Table 1, spot 4) is also up-regulated in
response to the miR-153-3p mimic whilst the expression of mortalin (Heat shock 70kDa pro-
tein 9-HSPA9) (Table 1, spot 6) is down-regulated. The STIP1 protein forms a complex with
HSC70 and HSP90 [24] and STIP1 is elevated in serum from patients with neuro-Behçet's dis-
ease [25]. We also found that 14-3-3 protein epsilon (14-3-3E) (Table 1, spot 15), involved in
cell cycle regulation, PI3-Akt signaling, Hippo signaling, Neurotrophin signaling, and viral car-
cinogenesis (Fig 4), is down-regulated in response to miR-153-3p inhibition [26]. Several 14-3-
3 isoforms are present in Lewy bodies suggesting the involvement of 14-3-3 proteins in neuro-
degeneration [27]. The regulation of 14-3-3 proteins by microRNAs has been documented
where 14-3-3zeta is a direct target of miR-451 [28].
Fig 2. Comparative proteomic profiling in SH-SY5Y. Two-dimensional gels of control mimic, miR-153-3p mimic, control antagomir and miR-153-3p
antagomir transfected cells. n = 3 for all experiments. Numbers (1–15) represent differentially expressed protein spots identified by MS, reported in Table 1.
doi:10.1371/journal.pone.0143969.g002
miR153-3p and miR205-5p Protein Targets in SH-SY5Y Cells
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In response to miR-153-3p inhibition cofilin-1 was down-regulated (Table 1, spot 32), veri-
fied by western blot analysis (Fig 5B), whilst miR-205-5p overexpression resulted in cofilin-1
up-regulation (Table 1, spot 18). Cofilin-1 is involved in protein translocation, rod-shaped
actin bundle formation and is activated by amyloid-beta (Abeta 1–42) [29, 30]. Rod-shaped
actin bundles are sites for amyloid-precursor protein accumulation in AD [31]. Western blot
analysis confirmed cofilin-1 regulation by the miR-205-5p mimic (Fig 5C) and the antagomir
(Fig 5D).
Our data indicates that both miR-205-5p and miR-153-3p influence direct and peripheral
processes associated with neurodegenerative disorders, providing clues towards the possible
regulation of key pathways (S4 Table, Fig 4).
Peroxiredoxins are regulated by both miR-153-3p and miR205-5p. We found that miR-
153-3p overexpression leads to an up-regulation of peroxiredoxin 2 (PRDX2) (Table 1, spot 1)
whilst miR-153-3p inhibition results in peroxiredoxin-4 (PRDX4) precursor up-regulation
(Table 1, spot 9). Similar effects were also observed for miR-205-5p (Table 1, spot 19 & 29).
The PRDX family protects cells from oxidative stress-induced apoptosis and have been associ-
ated with neurodegeneration [32]. PRDX2 overexpression in MN9D neuronal cells results in a
ROS decrease and prevention of 6-OHDA-induced ASK1 activation by regulating the redox
Fig 3. Comparative proteomic profiling in SH-SY5Y. Two-dimensional gels of control mimic, miR-205-5p mimic, control antagomir and miR-205-5p
antagomir transfected cells. n = 3 for all experiments. Numbers (16–33) represent differentially expressed protein spots identified by MS, reported in Table 1.
doi:10.1371/journal.pone.0143969.g003
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Table 1. List of differentially regulated proteins in SH-SY5Y cells in response to mimics and antagomirs of miR-153-3p andmiR-205-5p.
Spot
No.
UniProt
Accession
Description Sequence
coverage
Fold
change
Signiﬁcance p-
value
miR-153-3p mimic—upregulated proteins
1 P32119 Peroxiredoxin-2 27 1.66 ± 0.13 0.03
2 P11177 Pyruvate dehydrogenase beta subunit 12 2.26 ± 0.19 0.04
3 P09429 High mobility group protein B1 (HMGB-1) 26 1.64 ± 0.11 0.02
4 P25786 Proteasome subunit alpha type-1 isoform 2 20 1.49 ± 0.09 0.03
P31948 Stress-induced-phosphoprotein 1 13
miR-153-3p mimic—downregulated proteins
5 Q8IW75 x Serpin A12 precursor 1 1.44 ± 0.04 0.04
6 P38646 Heat shock 70kDa protein 9 (mortalin) 24 1.84 ± 0.22 0.003
7 Q9UHV9 Prefoldin subunit 2 16 2.34 ± 0.25 0.04
miR-153-3p antagomir—Upregulated proteins
8 P05388 60S acidic ribosomal protein P0 35 2.24 ± 0.13 0.05
9 Q13162 Peroxiredoxin-4 precursor 30 2.03 ± 0.43 0.05
Q14CN2 Ca2+-activated chloride channel protein 2 3
10 P22392 Human Nucleoside Diphosphate Kinase B (Nm23) 36 1.61 ± 0.14 0.008
miR-153-3p antagomir—downregulated proteins
11 P06733 Alpha-enolase 13 3.18 ± 0.09 0.01
12 P13929 Beta-enolase 22 1.84 ± 0.13 0.03
13 Q9UBR2 Cathepsin Z precursor 6 2.65 ± 0.16 0.01
14 P23528 Coﬁlin-1 53 2.11 ± 0.20 0.004
15 P68104 Elongation factor 1-alpha 1 10 2.55 ± 0.64 0.01
P62258 14-3-3 protein epsilon 24
miR-205-5p mimic—upregulated proteins
16 Q13765 Nascent-polypeptide-associated complex alpha (HSD48) 25 1.80 ± 0.28 0.05
17 P63241 Eukaryotic translation initiation factor 5A-1 isoform B 22 2.28 ± 0.27 0.05
18 P23528 Coﬁlin-1 43 2.11 ± 0.77 0.009
19 P32119 Peroxiredoxin-2 21 1.99 ± 0.03 0.05
20 P04083 Annexin A1 7 2.08 ± 0.16 0.04
21 P25786 Proteasome subunit alpha type-1 isoform 2 9 1.61 ± 0.16 0.001
22 Q13126 Methylthioadenosine phosphorylase 16 1.80 ± 0.24 0.04
23 Q13347 Eukaryotic translation initiation factor 3 subunit I 13 1.55 ± 0.03 0.04
24 P62333 y Proteasome subunit p42 3 1.90 ± 0.09 0.04
miR-205-5p mimic—downregulated proteins
25 P50213 Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial
precursor
23 2.02 ± 0.24 0.007
P04406 z Glyceraldehyde-3-phosphate dehydrogenase 4
26 Q8IW75 x Serpin A12 precursor 1 2.38 ± 0.50 0.03
miR-205-5p antagomir—upregulated proteins
27 Q13148 TAR DNA-binding protein 43 7 2.03 ± 0.09 0.01
28 Q07955 Serine/arginine-rich splicing factor 1 isoform 1 53 2.24 ± 0.58 0.04
29 Q13162 Peroxiredoxin-4 precursor 33 1.66 ± 0.09 0.04
miR-205-5p antagomir—downregulated proteins
30 P09382 Human Galectin-1 52 1.80 ± 0.22 0.03
31 P22392 Human Nucleoside Diphosphate Kinase B (Nm23) 24 1.55 ± 0.00 0.03
32 P23528 Coﬁlin-1 34 2.11 ± 0.30 0.02
(Continued)
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status of thioredoxin (Trx), whilst PRDX2 knockdown causes a ROS increase [33]. Cytosolic
PRDX2 (S3 Table) can also act as a chaperone protecting citrate synthase, insulin and SNCA
from stress-induced aggregation [34, 35]. We verified the miR-153-3p- and miR-205-5p-medi-
ated increase in PRDX2 by western blot analysis (Fig 5A and 5C). PRDX4 is putative tumor
driver where down-regulation of PRDX4 in glioblastoma multiformes (GBMs) results in
decreased cell growth and increased levels of ROS, DNA damage, and apoptosis [36].
The regulation of PRDXs by miR-153-3p and miR-205-5p suggest that miR-153-3p and
miR-205-5p may affect cellular ROS levels. Indeed, overexpression of miR-153-3p and miR-
205-5p causes significant ROS reduction (Fig 5E). Combined this indicate that miR-153-3p
and miR205-5p influence PRDX levels, which may affect ROS levels (Fig 5F).
miR-153-3p and miR-205-5p alter known cell cycle regulators
Numerous microRNAs are involved in the cell cycle, cancer proliferation and metastasis [37].
In response to miR-153-3p inhibition we identified Nucleoside diphosphate Kinase B (Nm23)
(Table 1, spot 10) and tumor suppressor alpha-enolase (Table 1, spot 11), two cell cycle
Table 1. (Continued)
Spot
No.
UniProt
Accession
Description Sequence
coverage
Fold
change
Signiﬁcance p-
value
33 Q13765 Nascent-polypeptide-associated complex alpha (HSD48) 25 1.69 ± 0.00 0.05
Q01105 x Protein SET 5
x, y, z
–Single peptides identiﬁed from individual protein spots in two (x), three (y) or seven (z) independent MALDI-MS detections. All the protein spots were
picked and analyzed from at-least two independent experiments. Fold change ± error are calculated with respect to control mimic and control inhibitor by
ImageMaster 2D platinum 7 (GE) software. The signiﬁcance was calculated using two-tailed t-test.
doi:10.1371/journal.pone.0143969.t001
Fig 4. Protein association network showing interconnecting relationships betweenmiR-153-3p and
miR-205-5p target proteins through key regulatory pathways. YWHAE: 14-3-3 epsilon protein; ENO1:
Alpha-enolase; ENO3: beta-enolase; IDH3A: Isocitrate dehydrogenase [NAD] subunit alpha; PDHB:
Pyruvate dehydrogenase complex beta subunit; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
doi:10.1371/journal.pone.0143969.g004
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regulatory proteins [38, 39]. miR-153-3p inhibition results in increased abundance of Nm23
(Fig 2, spot 10), known as a transcriptional activator of c-myc [40]. In contrast, alpha-enolase is
down-regulated in response to miR-153-3p inhibition (Table 1). Interestingly, alpha-enolase
can bind to the c-myc promoter, but in contrast to Nm23, represses c-myc expression [41].
We also found that altered levels of miR-205-5p affect proteins associated with tumor prolif-
eration and invasion (Table 1). miR-205-5p inhibition down-regulates Nm23 (Table 1, spot
31) and Protein SET (Fig 2, spot 33). Protein SET, part of the inhibitor of acetyltransferases
(INHAT) complex, is up-regulated in numerous tumors [42]. Interestingly, a jun co-activator,
Nascent-polypeptide-associated complex alpha (HSD48), was up-regulated (Table 1, spot 16)
by miR-205-5p overexpression whilst its expression decreased (Table 1, spot 33) by miR-205-
5p inhibition [43, 44]. HSD48 (NACA) regulation by miR-205-5p was confirmed by western
blot analysis (Figs 5C and 4D).
Galectin-1, a beta-galactoside binding protein associated with cell proliferation and differ-
entiation is also down-regulated in response to miR-205-5p inhibition (Table 1, spot 30) [45].
Combined these results indicate that miR-153-3p and miR-205-5p may play a role in cell
proliferation and migration involving various target proteins.
Fig 5. Verification of differentially expressed proteins byWestern blot analysis and ROS changes in
response to miR-153-3p andmiR-205-5p.Western blot analysis showing effect of miR-153-3p mimic on (A)
PRDX2 and HMGB1 levels (B) effect of miR-153-3p antagomir on Cfl1 levels, (C) effect of miR-205-5p mimic
on PRDX2, NACA and Cfl1 levels, (D) effect of miR-205-5p antagomir on NACA and Cfl1 levels. (E)
Quantification of ROS levels in SH-SY5Y cells by modulating miR-153-3p and miR-205-5p levels.
Percentage change in DCF fluorescence compared to control is shown. (F) Proposed pathway for ROS
reduction due to miR-153-3p and miR-205-5p by regulation of PRDX2. Error bars indicate SEM (n = 3); *,
p < 0.05; **, p < 0.01, ***; p < 0.001.
doi:10.1371/journal.pone.0143969.g005
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miR-153-3p and miR-205-5p have roles in regulating proteins involved in
metabolic pathways
Glucose stimulation increases miR-153 expression and miR-153 expression is reduced in
PTPRN2 (Protein tyrosine phosphatase receptor type N polypeptide 2) mouse knockout mod-
els [46]. We found that the expression of adipokine Serpin A12 (SERPINA12) (Table 1, spot 5)
is down-regulated in response to miR-153-3p overexpression whilst the pyruvate dehydroge-
nase complex beta subunit (PDHB) (Table 1, spot 2), a key enzyme linking the glycolytic path-
way to the TCA cycle, is up-regulated (Table 1) [47].
miR-153-3p overexpression also resulted in the up-regulation of High mobility group pro-
tein B1 (HMGB1) (Table 1, spot 3), involved in remodeling chromatin affecting gene expres-
sion (S3 Table) [48]. HMGB1-deficient mice have lethal hypoglycemia causing death within 24
hours [49]. To verify the up-regulation of HMGB1 in response to miR-153-3p overexpression
we performed western blot analysis (Fig 5A). Interestingly, cofilin-1 (CFL1) (Table 1, spot 14),
which decreases in abundance as a result of miR-153-3p inhibition, is shown to act as glucocor-
ticoid receptor inhibitor [50].
Similar to miR-153-3p, miR-205-5p also down-regulates Serpin A12 (Table 1, spot 26). Fur-
thermore, miR-205-5p down-regulates isocitrate dehydrogenase [NAD] subunit alpha
(IDH3A) (Table 1, spot 25), a key enzyme in the TCA cycle and GAPDH (Table 1, spot 25)[51,
52]. miR-205-5p also up-regulates Annexin A1 (Table 1, spot 20), a protein that regulates
phospholipase A2 activity [53].
Collectively, miR-153-3p and miR-205-5p appears to regulate proteins involved in meta-
bolic pathways and in particular carbohydrate metabolism (S4 Table).
miR-205-5p is associated with transcriptional regulation
miR-205-5p appears to be affecting the abundance of proteins that influence mRNA expression
and processing (Table 1 and Fig 2). The serine/arginine-rich splicing factor 1 (SRSF-1)
(Table 1, spot 28), which ensures splicing accuracy and regulates alternative splicing, is up-reg-
ulated in response to miR-205-5p inhibition [54]. Indeed, HSD48 (Table 1, spot 16 & 33),
which is regulated by miR-205-5p, is a transcription regulator [55]. miR-205-5p inhibition also
causes increased abundance of the TAR DNA-binding protein 43 (TDP-43) (Table 1, S3 Table,
spot 27) that promotes CFTR exon skipping and regulates transcription [56]. Nm23, a gene
expression modulator, is also regulated by miR-205-5p showing decreased levels in response to
miR-205-5p inhibition (Table 1, spot 31) [57].
As microRNAs are most commonly involved in translational regulation, the up-regulation
of eukaryotic translation initiation factor 5A-1 isoform B (EIF5A) (Table 1, spot 17) and
(EIF3I) (Table 1, spot 23), in response to miR-205-5p was not surprising.
Concluding remarks
MicroRNA biology is complex and we have shown that miR-153-3p and miR-205-5p influ-
ences the abundance of numerous proteins integral to many biological processes in neuroblas-
toma cells (Fig 4, S3 Table). Interestingly, we observed that some proteins (cofilin-1 and
HSFD48) show reciprocal regulatory effects in response to miRNA mimic and antagomir
whilst other proteins did not show this reciprocal regulation. This suggests that the proteins
identified in this study represent a combination of direct and indirect targets of miR-153-3p
and miR-205-5p.
Some of these processes associated with the identified proteins are fundamental in
nature whilst others are specifically associated with cell survival, cell proliferation and
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neuroprotection. Although we acknowledge that the altered abundance of a small number of
proteins in a pathway may not necessarily indicate that the entire pathway is affected, our
study highlights that to fully understand microRNA-mediated processes a holistic approach is
needed, which will pave the way for further insight into neuronal processes associated with
normal development and disease.
Supporting Information
S1 Fig. MS/MS annotated spectra of the proteins identified with single peptide for (A) spot
5 (Q81W75x), Serpin A12 precursor (Mascot score: 32, score> 16 indicates homology,
expect 0.0072); (B) spot 33 (Q01105x), Protein SET (Mascot score: 58, score> 37 indicates
identity, expect 6.2e-05); (C) spot 24 (P62333y), Proteasome subunit p42 (Mascot score: 19,
score> 18 indicates homology, expect 0.05); (D) spot 25 (P04406z), Glyceraldehyde-
3-phosphate dehydrogenase (Mascot score: 67, score> 38 indicates identity, expect 2.6e-
05). Shown are representative spectra for the peptide sequence shown at the top of each spec-
trum. The spectra are derived from Mascot search results.
(TIF)
S2 Fig. Molecular map of the 26S proteosome showing proteins involved in ubiquitin medi-
ated proteolysis. Proteasome subunit alpha type-1 isoform 2 (PSMA1) (regulated by miR-153-
3p and miR-205-5p) and proteasome subunit p42 (PSMC6) (regulated by miR-205-5p) are
integral parts of the 26S proteosome.
(TIF)
S1 Table. List of primary antibodies used in this study.
(DOCX)
S2 Table. Details of identified proteins by mass spectrometry.
(XLSX)
S3 Table. GO annotation of all proteins identified showing molecular function and cellular
location.
(DOCX)
S4 Table. Cellular processes and pathway analysis of the differentially regulated proteins in
response to mimics and antagomirs of miR-153-3p and miR-205-5p.
(DOCX)
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